ישראל - עברית - Ministry of Health

a. levy dental co. ltd, israel - benzocaine - ג'ל - benzocaine 20 %w/w - benzocaine - benzocaine - hurricaine is designed for any dental procedure in which topical anesthesia is desired. hurricaine is also used for temporary relief of occasional minor irritation and pain associated with : canker sores, sore mouth and throat , minor injury of the mouth and gums caused by dentures or orthodentic appliances.

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - הזנת השיער

ישראל - עברית - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - חפיפת שיער

ישראל - עברית - Ministry of Health

מדיליין בעמ - עיצוב השיער

ישראל - עברית - Ministry of Health

מדיליין בעמ - עיצוב השיער

ישראל - עברית - Ministry of Health

הנקל סוד - רעישל הנזה

ישראל - עברית - Ministry of Health

לי השקעות בעמ - שיפור מראה השיער

ישראל - עברית - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 8000 iu / 0.8 ml - erythropoietin

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.